Start On Your Path To Better Hearing

Click to call
703-820-3800

703-820-3800

5232 Dawes Avenue
Alexandria, VA 22311

COVID-19 Update: At this time there will be no walk-in hours. Repairs and supplies can be handled by appointment only for Curbside Care.  We are complying with CDC guidelines by wearing masks and gloves and maintaining a disinfected office and equipment. Please call for details and to schedule, 9-5, M-F

Latest Hearing Industry News

Some viruses, such as measles, mumps and meningitis, can cause hearing difficulties, but what about SARS-CoV-2, the virus that causes COVID-19? In the first few months of the pandemic, a rapid systematic review of COVID-19 and hearing difficulties revealed a possible link between COVID-19 and audio-vestibular symptoms (hearing loss, tinnitus and vertigo). However, both the quantity and quality of the early studies were

Read More


Cases of sudden hearing loss increased during the coronavirus pandemic, according to a new study comparing admissions to ear, nose and throat (ENT) services before and during the outbreak. The study was carried out by three otolaryngology specialists, Assoc. Prof. Vural Fidan, Dr. Handan Koyuncu and Dr. Yaşar Okan Akın, and published in the peer-reviewed American Journal of Otolaryngology. While

Read More


Turning down the music at your fitness classes won't affect the intensity of your workout, researchers say. It's common for fitness instructors to crank up the volume -- sometimes to levels loud enough to damage hearing -- because they think it will help students work harder. But researchers at the University of Maryland School of Medicine found there's no link

Read More


New research shows teprotumumab, the only FDA-approved treatment for thyroid eye disease (TED), may lead to more frequent instances of hearing loss or muffled hearing than previously thought. Study results were presented at ENDO 2021, the Endocrine Society’s annual meeting, which took place from March 20-23, 2021. Teprotumumab is a targeted inhibitor of the insulin-like growth factor-1 receptor that is administered to patients once every 3 weeks

Read More


According to the World Health Organization, around 466 million people worldwide have disabling hearing loss, a number the organization projects will double by 2050 to affect 1 in 10 people. However, a groundbreaking Creighton University School of Medicine study has identified a drug that has the potential to protect against or treat hearing loss in humans. The findings are significant

Read More